CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542

Positive
AI Analysis

Summary

BofA Securities adjusted its price target on Madrigal Pharmaceuticals to $553 from $542, representing a modest upward revision.

Importance:2/10
Sentiment:
0.30
price_target_adjustmentanalyst_noteequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 22, 2026 12:26 PM

Read Original